Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

BACKGROUND: Influenza and its associated diseases are a major cause of morbidity and mortality. The United States Advisory Committee on Immunization Practices recommends influenza vaccination for everyone over 6 months of age. The failure of the flu vaccine in 2014–2015 demonstrates the need for a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Fullen, Daniel J., Noulin, Nicolas, Catchpole, Andrew, Fathi, Hosnieh, Murray, Edward J., Mann, Alex, Eze, Kingsley, Balaratnam, Ganesh, Borley, Daryl W., Gilbert, Anthony, Lambkin-Williams, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711822/
https://www.ncbi.nlm.nih.gov/pubmed/26761707
http://dx.doi.org/10.1371/journal.pone.0145902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711822/
https://www.ncbi.nlm.nih.gov/pubmed/26761707
http://dx.doi.org/10.1371/journal.pone.0145902

Ejemplares similares